Literature DB >> 9484963

Pleural tuberculosis in Harare, Zimbabwe: the relationship between human immunodeficiency virus, CD4 lymphocyte count, granuloma formation and disseminated disease.

R S Heyderman1, R Makunike, T Muza, M Odwee, G Kadzirange, J Manyemba, C Muchedzi, B Ndemera, Z A Gomo, L K Gwanzura, P R Mason.   

Abstract

OBJECTIVE: To elucidate the relationship between HIV, CD4+ count and pleural TB.
METHOD: In a prospective study, 94 patients presenting at two large Harare hospitals with clinically suspected pleural TB were enrolled over a 10-month period. All underwent standardized evaluation, closed pleural aspiration and biopsy. Patients receiving directly observed anti-TB therapy were followed-up.
RESULTS: Pleural TB was diagnosed in 90 individuals (median age 33 years; range 18-65; 64 males); the seroprevalence of HIV was 85%. HIV-positive patients were older than HIV-negative individuals (median age 33 vs 23 years, P = 0.013) and had a significantly lower median CD4+ count (191 vs 1106 x 10(6)/l respectively, P = 0.004). A CD4+ count of <200 x 10(6)/l was associated with a length of illness >30 days (65% vs 37%; P = 0.05), a positive pleural fluid smear (37% vs 0%; P = 0.0006) and a positive pleural biopsy Ziehl-Neelsen stain (35% vs 7%; P = 0.021). However, a relationship between CD4+ count and either pleural granuloma formation or radiological evidence of disseminated disease was not observed.
CONCLUSION: In sub-Saharan Africa, TB pleural effusions have become associated with older age, a chronic onset, and an increased mycobacterial load. These data emphasize the complex relationship between pleural TB, HIV infection and a low CD4+ count.

Entities:  

Mesh:

Year:  1998        PMID: 9484963     DOI: 10.1046/j.1365-3156.1998.00167.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  10 in total

1.  HIV Treatment in Developing Countries.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

Review 2.  Tuberculous Pleural Effusion.

Authors:  Leah A Cohen; Richard W Light
Journal:  Turk Thorac J       Date:  2015-01-01

3.  Polyfunctional Mycobacterium tuberculosis-specific effector memory CD4+ T cells at sites of pleural TB.

Authors:  L El Fenniri; Z Toossi; H Aung; G El Iraki; J Bourkkadi; J Benamor; A Laskri; N Berrada; A Benjouad; H Mayanja-Kizza; M R Betts; R El Aouad; D H Canaday
Journal:  Tuberculosis (Edinb)       Date:  2011-04-02       Impact factor: 3.131

Review 4.  Clinical Aspects of Adult Tuberculosis.

Authors:  Robert Loddenkemper; Marc Lipman; Alimuddin Zumla
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-06       Impact factor: 6.915

Review 5.  HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis?

Authors:  Collin R Diedrich; Joanne L Flynn
Journal:  Infect Immun       Date:  2011-01-18       Impact factor: 3.441

Review 6.  A systematic review of the epidemiology, immunopathogenesis, diagnosis, and treatment of pleural TB in HIV-infected patients.

Authors:  A Aljohaney; K Amjadi; G G Alvarez
Journal:  Clin Dev Immunol       Date:  2012-03-14

Review 7.  Pleural effusion: diagnosis, treatment, and management.

Authors:  Vinaya S Karkhanis; Jyotsna M Joshi
Journal:  Open Access Emerg Med       Date:  2012-06-22

8.  Focused assessment with sonography for HIV-associated tuberculosis (FASH): a short protocol and a pictorial review.

Authors:  Tom Heller; Claudia Wallrauch; Sam Goblirsch; Enrico Brunetti
Journal:  Crit Ultrasound J       Date:  2012-11-21

9.  Clinical profile, etiology, and management of hydropneumothorax: An Indian experience.

Authors:  Vasunethra Kasargod; Nilkanth Tukaram Awad
Journal:  Lung India       Date:  2016 May-Jun

10.  Relationship Between HIV Coinfection, Interleukin 10 Production, and Mycobacterium tuberculosis in Human Lymph Node Granulomas.

Authors:  Collin R Diedrich; Jennifer O'Hern; Maximiliano G Gutierrez; Nafiesa Allie; Patricia Papier; Graeme Meintjes; Anna K Coussens; Helen Wainwright; Robert J Wilkinson
Journal:  J Infect Dis       Date:  2016-07-26       Impact factor: 5.226

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.